SSL Secure
NAD+NAD+ for addictionNAD+ addiction recoveryNAD+ detox

NAD+ for Addiction Recovery: Detox Support & Treatment Guide

Learn how NAD+ for addiction recovery supports detox from alcohol, opioids, and substances. IV therapy protocols, timelines, and clinical evidence.

Published January 15, 2026Updated April 8, 202610 min read

Written by

Glunova Medical Team

Clinical Research & Health Content

Editorially reviewed by

Glunova Medical Review Board

Medical Advisory Panel

This guide is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Review medication, dosing, and handling decisions with a licensed healthcare professional.
## NAD+ in Addiction Recovery: Mechanism, Protocols, and Clinical Evidence NAD+ therapy has been used in addiction medicine since the 1960s, when early practitioners observed that high-dose IV NAD+ appeared to reduce withdrawal symptoms and cravings. Modern research is beginning to clarify the biochemical mechanisms behind these observations. We want to be clear from the start: NAD+ is not a magic bullet for addiction. But when we look at the biology, it becomes obvious why restoring cellular energy should be part of the conversation. ## The NAD+ Depletion Cycle in Addiction Substance abuse and NAD+ depletion form a self-reinforcing loop that is difficult to break without intervention. Here is how it works: The substance itself depletes NAD+. Alcohol, for example, uses NAD+ as a cofactor during metabolism. The *Alcohol Research & Health* journal documented this process extensively, noting that chronic alcohol exposure can reduce hepatic NAD+ by up to 40%. Opioids, stimulants, and benzodiazepines each deplete NAD+ through slightly different mechanisms, but the end result is the same: cells that cannot produce adequate energy. When cellular energy drops, neurotransmitter balance suffers. Dopamine and serotonin production requires energy-intensive enzymatic reactions. With depleted NAD+, the brain's reward circuitry malfunctions, driving stronger cravings for the substance that provides a temporary artificial dopamine surge. Meanwhile, the poor nutrition, disrupted sleep, and chronic stress that accompany active addiction further drain NAD+ stores. Each pass through this cycle leaves the individual more depleted than the last. ## What the Research Shows ### Clinical Evidence A 2019 double-blind pilot study in the *Journal of Psychoactive Drugs* administered IV NAD+ to patients undergoing substance withdrawal. The treatment group showed reduced craving scores and improved withdrawal tolerance compared to placebo. While the sample size was small, the results were consistent with the mechanistic predictions. ### Mechanistic Evidence A 2021 comprehensive review in *Nature Reviews Molecular Cell Biology* detailed how NAD+ depletion disrupts virtually every cellular process relevant to addiction recovery: energy production, DNA repair, inflammation control, and circadian rhythm regulation. A 2020 review in *Neuroscience & Biobehavioral Reviews* specifically examined the relationship between NAD+ metabolism and addictive behaviors, concluding that NAD+ restoration represents a plausible adjunctive strategy. ### What We Still Need Large-scale, multi-site randomized controlled trials have not been completed. The existing evidence, while promising, comes from small studies and extensive clinical observation. We are honest about this limitation. ## How NAD+ Supports Recovery ### During Acute Detoxification NAD+ IV therapy during the first 5 to 10 days of detox may help by restoring cellular energy production when the body is under maximum stress, supporting neurotransmitter rebalancing during the critical withdrawal window, and reducing the severity of withdrawal symptoms. A typical acute detox protocol in a clinical setting involves 500 to 1000mg of NAD+ administered intravenously over 4 to 8 hours daily for 5 to 10 consecutive days, always under medical supervision and combined with standard detox care. ### During Post-Acute Recovery After the initial detox phase, patients transition to less intensive protocols. Weeks 2 through 4 typically involve IV sessions of 250 to 500mg two to three times weekly, or subcutaneous injections of 150 to 200mg daily. By months 2 and 3, most patients move to weekly IV sessions or subcutaneous injections three times weekly. ### Long-Term Maintenance The maintenance phase, which may last 6 to 12 months or longer, uses monthly IV boosters of 250 to 500mg or subcutaneous injections of 100 to 150mg two to three times weekly. This ongoing support helps sustain cellular health during the vulnerable early recovery period. ## What NAD+ Therapy Cannot Do We would be doing you a disservice if we did not state this plainly. NAD+ therapy alone will not cure addiction. It will not prevent relapse without comprehensive treatment. It should never be the only intervention. And it is not appropriate without proper medical supervision. The clinics that advertise NAD+ as a standalone cure for addiction are doing patients a serious disservice. NAD+ works best as one component of a comprehensive program that includes medical supervision for safe detox, counseling and behavioral therapy to address root causes, peer support through groups and community, and lifestyle restructuring around diet, exercise, and sleep. ## Finding Quality Treatment If you are considering NAD+ as part of an addiction recovery program, here is what to look for: medical supervision on-site with addiction-trained physicians, a comprehensive treatment approach that does not rely on NAD+ alone, licensed healthcare provider — [find a clinic near you](/for-clinics)s administering IV infusions, transparent pricing without pressure tactics, and an aftercare plan that extends beyond the initial treatment period. Red flags include any facility offering NAD+ as its sole treatment, making guarantees about outcomes, or operating without proper medical oversight. ## The Bottom Line NAD+ therapy addresses a real biological problem that addiction creates. Substance abuse depletes the cellular fuel that your brain and body need to heal, and restoring that fuel can meaningfully support recovery. The pilot study data is encouraging, the mechanistic evidence is strong, and clinical observations over the past decade have been consistently positive. But NAD+ is one piece of a much larger puzzle. Recovery requires professional treatment, personal commitment, community support, and time. If you or someone you love is struggling with addiction, please seek comprehensive professional help. *This guide is educational and does not constitute medical advice. Addiction treatment requires professional medical supervision. If you or someone you know needs help, call SAMHSA's National Helpline at 1-800-662-4357.* For more information, see our guide on [NAD+ injection benefits](/guides/nad-injection-benefits-anti-aging-energy-recovery-guide). Learn more about [NAD+ for anxiety and depression](/guides/nad-for-anxiety-depression-mental-health-guide) to enhance your understanding. You may also find our article on [NAD+ for brain health](/guides/nad-for-brain-health-cognitive-function-memory) helpful. Our detailed guide on [NAD+ IV therapy vs injection](/guides/nad-iv-therapy-vs-injection-complete-guide) covers this topic in depth. Explore our resource on [NAD+ side effects and safety](/guides/nad-side-effects-safety-what-to-expect) for additional insights. For a deeper dive, check out [NAD+ injection costs](/guides/nad-injection-cost-price-guide-2026). --- ## References - [Alcohol, oxidative stress, and free radical damage](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826793/). *Alcohol Research & Health*, 2003. - [NAD+ metabolism and its roles in cellular processes during ageing](https://doi.org/10.1038/s41580-020-00313-x). *Nature Reviews Molecular Cell Biology*, 2021. - [Nicotinamide adenine dinucleotide (NAD) and addiction](https://doi.org/10.1016/j.neubiorev.2020.06.015). *Neuroscience & Biobehavioral Reviews*, 2020. - [The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling](https://doi.org/10.1016/j.cell.2013.06.016). *Cell*, 2013. - [Intravenous NAD+ for the Treatment of Withdrawal in Substance Use Disorder: A Double-blind Pilot Study](https://doi.org/10.1080/02791072.2019.1566553). *Journal of Psychoactive Drugs*, 2019.

Frequently Asked Questions

Sources & References

  1. 1
  2. 2
  3. 3
    Nicotinamide adenine dinucleotide (NAD) and addiction

    Neuroscience & Biobehavioral Reviews, 2020

  4. 4
  5. 5